البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)
Venlafaxine hydrochloride
Krka UK Ltd
N06AX16
Venlafaxine hydrochloride
75mg
Modified-release capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030400; GTIN: 5391512450656
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Alventa XL is and what it is used for 2. Before you take Alventa XL 3. How to take Alventa XL 4. Possible side effects 5. How to store Alventa XL 6. Further information 1. WHAT ALVENTA XL IS AND WHAT IT IS USED FOR Alventa XL is an antidepressant that belongs to a group of medicines called serotonin and norepinephrine reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. It is thought that people who are depressed and/or anxious have lower levels of serotonin and noradrenaline in the brain. It is not fully understood how antidepressants work, but they may help by increasing the levels of serotonin and noradrenaline in the brain. Alventa XL is a treatment for adults with depression. Alventa XL is also a treatment for adults with the following anxiety disorder: social anxiety disorder (fear or avoidance of social situations). Treating depression or anxiety disorders properly is important to help you get better. If it is not treated, your condition may not go away and may become more serious and more difficult to treat. 2. BEFORE YOU TAKE ALVENTA XL DO NOT TAKE ALVENTA XL • If you are allergic to venlafaxine or any of the other ingredients of Alventa XL. • If you are also taking or have taken any time within the last 14 days any medicines known as irreversible monoamine oxidase inhibitors (MAOIs), used to treat depression or Parkinson’s disease. Taking an irreversible MAOI together with other medicines, including Alventa XL, can cause se اقرأ الوثيقة كاملة
OBJECT 1 ALVENTA XL 75 MG PROLONGED-RELEASE CAPSULES, HARD Summary of Product Characteristics Updated 20-May-2016 | Consilient Health Ltd 1. Name of the medicinal product Alventa XL 75 mg prolonged release capsules, hard 2. Qualitative and quantitative composition Alventa XL 75 mg: Each prolonged release capsule, hard, contains 75 mg venlafaxine (as 84.85 mg venlafaxine hydrochloride). Excipient with known effect: 75 mg capsule sucrose 65 mg For a full list of excipients, see section 6.1. 3. Pharmaceutical form Prolonged release capsule, hard. Alventa XL 75 mg_: _opaque, light pink, prolonged release, hard gelatine capsules containing of white to off-white pellets. 4. Clinical particulars 4.1 Therapeutic indications Treatment of major depressive episodes. For prevention of recurrence of major depressive episodes. Treatment of Social Anxiety Disorder (SAD). 4.2 Posology and method of administration Posology Major depressive episodes The recommended starting dose for prolonged-release venlafaxine is 75 mg given once daily. Patients not responding to the initial 75 mg/day dose may benefit from dose increases up to a maximum dose of 375 mg/day. Dosage increases can be made at intervals of 2 weeks or more. If clinically warranted due to symptom severity, dose increases can be made at more frequent intervals, but not less than 4 days. Because of the risk of dose-related adverse effects, dose increments should be made only after a clinical evaluation (see section 4.4). The lowest effective dose should be maintained. Patients should be treated for a sufficient period of time, usually several months or longer. Treatment should be reassessed regularly on a case-by-case basis. Longer-term treatment may also be appropriate for prevention of recurrence of major depressive episodes (MDE). In most of the cases, the recommended dose in prevention of recurrence of MDE is the same as the one used during the current episode. Antidepressive medicinal products should continue for at least six months following remission. Social anxiet اقرأ الوثيقة كاملة